Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

Ovarian cancer is the leading cause of death from gynecologic malignancy in the Western world. This is due, in part, to the fact that despite standard treatment of surgery and platinum/paclitaxel most patients recur with ultimately chemoresistant disease. Ovarian cancer is a unique form of solid tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Emmings, Edith, Mullany, Sally, Chang, Zenas, Landen, Charles N., Linder, Stig, Bazzaro, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337358/
https://www.ncbi.nlm.nih.gov/pubmed/30626133
http://dx.doi.org/10.3390/ijms20010229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337358/
https://www.ncbi.nlm.nih.gov/pubmed/30626133
http://dx.doi.org/10.3390/ijms20010229

Ejemplares similares